Bisciglia M
~ 0  results:
Search for persons X
?
2

CHANNELOPATHIES AND RELATED DISORDERS:

Bisciglia, M. ; Kadhim, H. ; Lecomte, S....
Neuromuscular Disorders.  31 (2021)  - p. S117-S118 , 2021
 
?
3

FSHD / OPMD / MYOTONIC DYSTROPHY:

Masingue, M. ; Bisciglia, M. ; Chanut, A....
Neuromuscular Disorders.  30 (2020)  - p. S111 , 2020
 
?
4

MITOCHONDRIAL DISEASES & METABOLIC MYOPATHIES:

Bisciglia, M. ; Busson, A. ; Marangoni, M....
Neuromuscular Disorders.  30 (2020)  - p. S140 , 2020
 
?
5

Diagnostic des myopathies congénitales:

Bisciglia, M. ; Malfatti, E.
Journal de Pédiatrie et de Puériculture.  33 (2020)  6 - p. 260-267 , 2020
 
?
 
?
7

Nephrotic Syndrome and Plasmapheresis:

Russo, G.E. ; Bonello, M. ; Bauco, B....
The International Journal of Artificial Organs.  23 (2000)  2 - p. 111-113 , 2000
 
?
9

Diagnostic des myopathies congénitales:

Bisciglia, M ; Malfatti, E
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jpp.2020.09.007.  , 2020
 
?
10

Diagnostic des myopathies congénitales:

Bisciglia, M ; Malfatti, E
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jpp.2020.09.007.  , 2020
 
?
11

Diagnostic des myopathies congénitales:

Bisciglia, M ; Malfatti, E
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jpp.2020.09.007.  , 2020
 
?
12

New treatments for myasthenia: a focus on antisense oligonu..:

Angelini C ; Martignago S ; Bisciglia M
http://www.dovepress.com/new-treatments-for-myasthenia-a-focus-on-antisense-oligonucleotides-a11920.  , 2013
 
?
13

P-1 Prognostic factors and course of myasthenia gravis:

Albertini, E ; Martignago, S ; Bisciglia, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235855.  , 2011
 
?
14

P-4 Evaluating therapy outcome in Mysthenia Gravis:

Bisciglia, M ; Albertini, M.E ; Martignago, S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235869.  , 2011
 
?
15

Asymptomatic and symptomatic deep venous thrombosis in hosp..:

Loffredo L ; Vidili G ; Sciacqua A...
info:eu-repo/semantics/altIdentifier/pmid/36451162.  , 2022
 
1-15